You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Genome Research this week: post-zygotic mutations in diabetes development, single-cell RNA sequencing study of aging, and more.
Weizmann Institute of Science researchers have developed an Escherichia coli strain that consumes carbon dioxide, Discover magazine reports.
Forbes reports on firms using artificial intelligence to diagnose rare genetic diseases.
The partners will evaluate circulating tumor cell-based biomarker panels as potential new tests for use on Ikonisys' Ikoniscope fluorescence microscopy system.
Mobidiag signed agreements for its Amplidiag and Novodiag products with Alab in Poland and the Ukraine; Biogenetix in Romania; and Theranostica in Israel.
PetaGene is expanding further into South Asia and other regions by naming Dubai-based Alliance Global as its exclusive partner in several countries.
In PLOS this week: genetic analysis of Iranian ethnic groups, genome-wide methylation analysis of cataracts among giant pandas, and more.
Denisovans, an extinct group of humans, likely shared some anatomical traits with Neanderthals and humans but also had some that were specific to them.
Researchers examine changes in the genomes of emmer wheat populations where the climate has warmed, the BBC reports.
In Cell this week: microinjection of CRISPR-Cas9 enables targeted mutations in Anolis, melanoma proteomic profiling, and more.
The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.
NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.
Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.
In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.